India's Largest Database on New Projects
Ranbaxy, Daiichi Sankyo to expand business in Mexico
3 August 2011: Ranbaxy Laboratories and the parent firm Daiichi Sankyo plans to expand business in Mexico.
The companies will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico by December 2011.
Daiichi Sankyo and Ranbaxy have agreed to expand the group's business in Mexico with the launch of Olmesartan Medoxomil," the two companies said in a joint statement.
Source: Economic Times